Cancer Care

 

 

Melanoma / Skin Cancer Program Clinical Trials

A clinical trial is one of the final steps in a long and careful cancer research process that is looking for better ways to prevent, diagnose, or treat cancer. Clinical trials test new medical approaches in patients with cancer, and are important to developing new treatments for cancer. Many of the "standard treatments" that patients with cancer receive today were developed based on the results of previous clinical trials.

The following is a list of clinical trials with which this cancer care program is currently involved. Talk to your doctor to find out if a clinical trial is right for you.

Kaposis sarcoma Clinical Trials
Reducing Disparities in Health for Vulnerable Populations in NH and VT: Journey Forward Cancer Survivor Care Planning in the Rural Northeast
Kaposis sarcoma
FED11061
Pace
Melanoma, skin Clinical Trials
A Multi-Center Study of High Dose Aldesleukin (Interleukin-2)+ Vemurafenib Therapy in Patients with BRAFV600 Mutation Positive Metastatic Melanoma
Melanoma, skin
F12115
Ernstoff
A Multi-Site Retrospective Observational Study Of Us Patients With Unresectable Or Metastatic Melanoma Receiving Ipilimumab (Yervoy®) As First-Line Therapy
Melanoma, skin
F13048
Ernstoff
A Multicenter, Double-blind, Placebo-controlled, Adaptive Phase 3 Trial of POL-103A Polyvalent Melanoma Vaccine in Post-resection Melanoma Patients with a High Risk of Recurrence
Melanoma, skin
F12076
Ernstoff
A Phase 1 Study of the Clinical and Immunologic Effects of ALT-803, a Novel Recombinant IL-15 Complex in Patients with Advanced Melanoma
Melanoma, skin
W14090
Ernstoff
A Phase III Randomized Study of Adjuvant Ipilimumab Anti-CTLA4 Therapy Versus High-Dose Interferon α-2b for Resected High-Risk Melanoma
Melanoma, skin
E1609
Ernstoff
A Randomized Phase II Study of Sequential Biotherapy With Aflibercept and High Dose IL-2 Versus High Dose IL-2 Alone in Patients With Inoperable Stage III or Stage IV Melanoma: Efficacy and Biomarker Study
Melanoma, skin
W11068
Ernstoff
A phase II trial of an Indoleamine2,3, dioxygenase-1 (IDO1) inhibitor (INCB024360) plus a multipeptide melanoma vaccine in patients with advanced melanoma (MELITAC 12.1)
Melanoma, skin
W13204
Ernstoff
Expanded Access of MK-3475 in Metastatic Melanoma Patients with Limited to No Treatment Options
Melanoma, skin
F14123
Ernstoff
Immunologic Evaluation of Peripheral Blood
Melanoma, skin
D0229
Ernstoff
Melanoma and Renal Tumor Tissue Bank
Melanoma, skin
D1013
Ernstoff
Modular phase II study to link targeted therapy to patients with pathway activated tumors: Module 1 - BKM120 for patients with PI3K-activated tumors
Melanoma, skin
F14086
Chamberlin
Phase III Randomized Study of Four Weeks High Dose IFN-α2b in Stage T2b No, T3a-bNo, T4a-b No, and T1-4, N1a, 2a (microscopic) Melanoma
Melanoma, skin
E1697
Ernstoff
Reducing Disparities in Health for Vulnerable Populations in NH and VT: Journey Forward Cancer Survivor Care Planning in the Rural Northeast
Melanoma, skin
FED11061
Pace
The High-Dose Aldesleukin (IL-2) `Select` Trial: A Prospective Tissue Collection Protocol to Investigate Predictove Models of Response to High Dose IL-2 Treatment in Patients with Advanced Melanoma
Melanoma, skin
W1043
Ernstoff
Ultrasound Evaluation of Sentinel Lymph Nodes in Melanoma Patients and in Patients with Melanocytic Tumors of Unknown Metastastic Potential (MELTUMP) or Atypical Spitz Nevus (ASN): A Prospective Data Base
Melanoma, skin
D1012
Ernstoff
Other Skin Clinical Trials
Phase III Trial of Enzalutamide (NSC #766085) versus Enzalutamide, Abiraterone and Prednisone for Castration Resistant Metastatic Prostate Cancer
Other Skin
A031201
Schell
Reducing Disparities in Health for Vulnerable Populations in NH and VT: Journey Forward Cancer Survivor Care Planning in the Rural Northeast
Other Skin
FED11061
Pace